Abacept treatment for patients with early active primary Sjögren's syndrome: OPEN-LABEL EXTENSION PHASE OF A RANDOMIZED CONTROLLED PHASE III TRIAL

S. Arends; J. F. Van Nimwegen; E. Mossel; G. S. Van Zuiden; K. Delli; A. J. Stel; B. Van der Vegt; E. A. Haacke; L. Olie; L. Los; G. M. Verstappen; S. A. Pringle; F. K. L. Spijkervet; F. G. M. Kroese; A. Vissink; H. Bootsma

doi:10.1136/annrheumdis-2020-eular.4439

Abacept treatment for patients with early active primary Sjögren's syndrome: OPEN-LABEL EXTENSION PHASE OF A RANDOMIZED CONTROLLED PHASE III TRIAL

S. Arends, J. F. Van Nimwegen, E. Mossel, G. S. Van Zuiden, K. Delli, A. J. Stel, B. Van der Vegt, E. A. Haacke, L. Olie, L. Los, G. M. Verstappen, S. A. Pringle, F. K. L. Spijkervet, F. G. M. Kroese, A. Vissink, H. Bootsma

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	102-102
Number of pages	1
Journal	Annals of the Rheumatic Diseases
Volume	79
DOIs	https://doi.org/10.1136/annrheumdis-2020-eular.4439
Publication status	Published - Jun-2020
Event	Annual European Congress of Rheumatology (EULAR) - Duration: 3-Jun-2020 → …

Access to Document

10.1136/annrheumdis-2020-eular.4439

https://ard.bmj.com/content/79/Suppl_1/102.2

Cite this

Arends, S., Van Nimwegen, J. F., Mossel, E., Van Zuiden, G. S., Delli, K., Stel, A. J., Van der Vegt, B., Haacke, E. A., Olie, L., Los, L., Verstappen, G. M., Pringle, S. A., Spijkervet, F. K. L., Kroese, F. G. M., Vissink, A., & Bootsma, H. (2020). Abacept treatment for patients with early active primary Sjögren's syndrome: OPEN-LABEL EXTENSION PHASE OF A RANDOMIZED CONTROLLED PHASE III TRIAL. Annals of the Rheumatic Diseases, 79, 102-102. https://doi.org/10.1136/annrheumdis-2020-eular.4439

Arends, S. ; Van Nimwegen, J. F. ; Mossel, E. ; Van Zuiden, G. S. ; Delli, K. ; Stel, A. J. ; Van der Vegt, B. ; Haacke, E. A. ; Olie, L. ; Los, L. ; Verstappen, G. M. ; Pringle, S. A. ; Spijkervet, F. K. L. ; Kroese, F. G. M. ; Vissink, A. ; Bootsma, H. / Abacept treatment for patients with early active primary Sjögren's syndrome : OPEN-LABEL EXTENSION PHASE OF A RANDOMIZED CONTROLLED PHASE III TRIAL. In: Annals of the Rheumatic Diseases. 2020 ; Vol. 79. pp. 102-102.

@article{02ecca9e1297442ea7d1918cb9968214,

title = "Abacept treatment for patients with early active primary Sj{\"o}gren's syndrome: OPEN-LABEL EXTENSION PHASE OF A RANDOMIZED CONTROLLED PHASE III TRIAL",

author = "S. Arends and {Van Nimwegen}, {J. F.} and E. Mossel and {Van Zuiden}, {G. S.} and K. Delli and Stel, {A. J.} and {Van der Vegt}, B. and Haacke, {E. A.} and L. Olie and L. Los and Verstappen, {G. M.} and Pringle, {S. A.} and Spijkervet, {F. K. L.} and Kroese, {F. G. M.} and A. Vissink and H. Bootsma",

year = "2020",

month = jun,

doi = "10.1136/annrheumdis-2020-eular.4439",

language = "English",

volume = "79",

pages = "102--102",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "BMJ PUBLISHING GROUP",

note = "Annual European Congress of Rheumatology (EULAR) ; Conference date: 03-06-2020",

}

Arends, S, Van Nimwegen, JF, Mossel, E, Van Zuiden, GS , Delli, K , Stel, AJ , Van der Vegt, B, Haacke, EA, Olie, L, Los, L , Verstappen, GM , Pringle, SA , Spijkervet, FKL , Kroese, FGM , Vissink, A & Bootsma, H 2020, 'Abacept treatment for patients with early active primary Sjögren's syndrome: OPEN-LABEL EXTENSION PHASE OF A RANDOMIZED CONTROLLED PHASE III TRIAL', Annals of the Rheumatic Diseases, vol. 79, pp. 102-102. https://doi.org/10.1136/annrheumdis-2020-eular.4439

Abacept treatment for patients with early active primary Sjögren's syndrome : OPEN-LABEL EXTENSION PHASE OF A RANDOMIZED CONTROLLED PHASE III TRIAL. / Arends, S.; Van Nimwegen, J. F.; Mossel, E.; Van Zuiden, G. S.; Delli, K.; Stel, A. J.; Van der Vegt, B.; Haacke, E. A.; Olie, L.; Los, L.; Verstappen, G. M.; Pringle, S. A.; Spijkervet, F. K. L.; Kroese, F. G. M.; Vissink, A.; Bootsma, H.

In: Annals of the Rheumatic Diseases, Vol. 79, 06.2020, p. 102-102.

Research output: Contribution to journal › Meeting Abstract › Academic

TY - JOUR

T1 - Abacept treatment for patients with early active primary Sjögren's syndrome

T2 - Annual European Congress of Rheumatology (EULAR)

AU - Arends, S.

AU - Van Nimwegen, J. F.

AU - Mossel, E.

AU - Van Zuiden, G. S.

AU - Delli, K.

AU - Stel, A. J.

AU - Van der Vegt, B.

AU - Haacke, E. A.

AU - Olie, L.

AU - Los, L.

AU - Verstappen, G. M.

AU - Pringle, S. A.

AU - Spijkervet, F. K. L.

AU - Kroese, F. G. M.

AU - Vissink, A.

AU - Bootsma, H.

PY - 2020/6

Y1 - 2020/6

U2 - 10.1136/annrheumdis-2020-eular.4439

DO - 10.1136/annrheumdis-2020-eular.4439

M3 - Meeting Abstract

VL - 79

SP - 102

EP - 102

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

Y2 - 3 June 2020

ER -